Activest Wealth Management’s Gilead Sciences GILD Stock Holding History

Activest Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.31K	Sell	42 -276	-87%	-$36.4K	﹤0.01%	696
2026 Q1	$44.3K	Buy	318 +14	+5%	+$1.96K	0.01%	361
2025 Q4	$37.3K	Sell	304 -3	-1%	-$365	0.01%	375
2025 Q3	$34.1K	Buy	307 +81	+36%	+$9.21K	0.01%	303
2025 Q2	$25.1K	Sell	226 -9	-4%	-$958	0.01%	287
2025 Q1	$26.3K	Buy	235 +227	+2,838%	+$23.4K	0.01%	255
2024 Q4	$739	Buy	+8	New	+$720	﹤0.01%	487

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Activest Wealth Management's GILD Position: Q2 2026 in Review

Activest Wealth Management reduced its Gilead Sciences (GILD) stake by 87% in Q2 2026, selling an estimated $36.4K and leaving 42 shares worth $5.31K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Activest Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $44.3K in Q1 2026. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Activest Wealth Management held 42 shares of Gilead Sciences worth $5.31K as of Q2 2026.
Activest Wealth Management sold 276 Gilead Sciences shares in Q2 2026, an estimated $36.4K.
Gilead Sciences made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #696 holding.
Activest Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
Activest Wealth Management's Gilead Sciences position peaked at $44.3K in Q1 2026.
911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.